{"id":"https://openalex.org/W2885675263","doi":"https://doi.org/10.1158/1538-7445.am2018-1744","title":"Abstract 1744: Reversal of advanced colitis-associated colon cancer by OMX, a novel oxygen carrier that immunosensitizes the hypoxic tumor microenvironment","display_name":"Abstract 1744: Reversal of advanced colitis-associated colon cancer by OMX, a novel oxygen carrier that immunosensitizes the hypoxic tumor microenvironment","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885675263","doi":"https://doi.org/10.1158/1538-7445.am2018-1744","mag":"2885675263"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-1744","doi":"https://doi.org/10.1158/1538-7445.am2018-1744","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-1744","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009759474","display_name":"Kevin G. Leong","orcid":"https://orcid.org/0000-0003-2450-2091","observed_orcids":["https://orcid.org/0000-0003-2450-2091"]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin G. Leong","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014411273","display_name":"Yuqiong Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuqiong Pan","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039465851","display_name":"Changan Guo","orcid":"https://orcid.org/0009-0001-0611-3239","observed_orcids":["https://orcid.org/0009-0001-0611-3239"]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changan Guo","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110572234","display_name":"Padmini Narayanan","orcid":"https://orcid.org/0000-0003-0163-9087","observed_orcids":["https://orcid.org/0000-0003-0163-9087"]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Padmini Narayanan","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033050158","display_name":"Jonathan A. Winger","orcid":"https://orcid.org/0000-0003-1413-3384","observed_orcids":["https://orcid.org/0000-0003-1413-3384"]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A. Winger","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112070179","display_name":"Stephen P. Cary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen P. Cary","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012959704","display_name":"Natacha Le Moan","orcid":"https://orcid.org/0000-0002-1674-4720","observed_orcids":["https://orcid.org/0000-0002-1674-4720"]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natacha Le Moan","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010037572","display_name":"Ana Krtolica","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099232","display_name":"Omniox (United States)","ror":"https://ror.org/011cheg80","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Krtolica","raw_affiliation_strings":["Omniox Inc., San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omniox Inc., San Carlos, CA","institution_ids":["https://openalex.org/I4210099232"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210099232"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"1744","last_page":"1744"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.1062999963760376,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.04729999974370003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colitis-associated-cancer","display_name":"colitis-associated colorectal cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.8500000238418579},{"id":"https://openalex.org/keywords/oxygen-carriers","display_name":"oxygen carriers","score":0.9169999957084656},{"id":"https://openalex.org/keywords/immunosensitization","display_name":"immunosensitization","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9110000133514404},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9269999861717224},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":1.0},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.7839999794960022},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6430000066757202},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7164238691329956},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.628287136554718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6053373217582703},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.5266392230987549},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5003535747528076},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.4901202619075775},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.48494747281074524},{"id":"https://openalex.org/C2778452354","wikidata":"https://www.wikidata.org/wiki/Q794084","display_name":"Azoxymethane","level":4,"score":0.46895211935043335},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.463933527469635},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4322061538696289},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.40937137603759766},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32415348291397095},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2214704155921936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1977948248386383},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-1744","doi":"https://doi.org/10.1158/1538-7445.am2018-1744","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-1744","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2739639075","https://openalex.org/W2547960541","https://openalex.org/W4407924032","https://openalex.org/W2740862279","https://openalex.org/W4400723564","https://openalex.org/W2609517390","https://openalex.org/W2887108134","https://openalex.org/W2594476307","https://openalex.org/W7082261207","https://openalex.org/W2588468689"],"abstract_inverted_index":{"Abstract":[0],"Chronic":[1],"inflammation":[2,15],"of":[3,39,45,50,65,73,94,194,213,224,328,332,335,399,425,445],"the":[4,53,92,346,381,438,446],"colon":[5,34,322,336,342,428],"increases":[6],"cancer":[7,35,429],"development":[8],"risk.":[9],"Ulcerative":[10],"colitis,":[11,52,96],"characterized":[12,243],"by":[13,17,23,216,221,364,430],"excessive":[14],"initiated":[16],"innate":[18],"immune":[19],"cells":[20,42,47,76,80,269],"and":[21,43,70,77,124,145,149,153,164,180,190,201,254,265,270,295,312,339,396],"exacerbated":[22],"a":[24,63,71,88,128,208,290,333,397,432],"dysregulation":[25],"in":[26,91,142,170,238,275,380],"adaptive":[27],"immunity,":[28],"can":[29],"give":[30],"rise":[31],"to":[32,102,133,137,249,279,367,375,388,393],"colitis-associated":[33,427],"(CAC).":[36],"Whereas":[37],"overactivity":[38],"effector":[40,66,120,157],"T":[41,67,121,158,297],"loss":[44],"immunosuppressive":[46,74,115,267,387],"are":[48,178,262,272,354],"hallmarks":[49],"ulcerative":[51,95],"opposite":[54],"is":[55],"true":[56],"for":[57,350,449],"CAC,":[58],"with":[59,97,196],"CAC":[60,103,176,187,214,240,244,260,276,301,309,314,369,382],"tumors":[61,148,177,261,277],"exhibiting":[62],"lack":[64],"cell":[68,122,159,298],"infiltration":[69,123,299],"preponderence":[72],"Treg":[75,162,268],"myeloid-derived":[78],"suppressor":[79],"(MDSCs).":[81],"Recently,":[82],"hypoxia":[83,98,112,136,185,195,294],"has":[84],"been":[85],"identified":[86],"as":[87],"potential":[89],"driver":[90],"pathogenesis":[93],"persisting":[99],"upon":[100],"progression":[101,246],"tumor":[104,116,135,151,172,188,245,310,315,370,383,394,440],"formation.":[105],"We":[106,242],"have":[107],"previously":[108],"demonstrated":[109],"that":[110,118,175,184,192,232,258,266,325,362,436],"(i)":[111],"generates":[113],"an":[114,203,377,386,389],"microenvironment":[117,384,441],"limits":[119],"activation,":[125],"(ii)":[126],"OMX,":[127,363,431],"first-in-class":[129],"anti-cancer":[130],"therapy":[131],"designed":[132],"reverse":[134],"enhance":[138],"immunotherapeutic":[139],"efficacy,":[140,168],"accumulates":[141],"preclinical":[143],"rodent":[144],"spontaneous":[146],"canine":[147],"reduces":[150,161],"hypoxia,":[152],"(iii)":[154],"OMX":[155,197,233,303,319,351],"promotes":[156],"infiltration,":[160],"cells,":[163],"enhances":[165],"checkpoint":[166],"inhibitor":[167],"resulting":[169],"greater":[171],"control.":[173],"Given":[174],"hypoxic":[179,368,439],"immunosuppressed,":[181],"we":[182,230,288],"hypothesized":[183],"drives":[186],"immunosuppression,":[189],"accordingly,":[191],"reversal":[193],"may":[198,372],"restore":[199],"immunosensitivity":[200],"elicit":[202],"anti-tumor":[204,236,352],"response.":[205],"Here,":[206],"using":[207],"chemically":[209],"induced":[210],"mouse":[211],"model":[212],"generated":[215],"administering":[217],"azoxymethane":[218],"(AOM)":[219],"followed":[220],"repeated":[222],"cycles":[223],"dextran":[225],"sulfate":[226],"sodium":[227],"(DSS)":[228],"exposure,":[229],"show":[231],"treatment":[234,306,320],"exhibits":[235],"efficacy":[237,353],"advanced":[239,259,426],"tumors.":[241,302],"from":[247,385],"8":[248],"12":[250],"weeks":[251],"post-tumor":[252],"induction,":[253],"confirmed":[255],"previous":[256],"reports":[257],"indeed":[263],"hypoxic,":[264],"MDSCs":[271],"more":[273],"abundant":[274],"relative":[278],"adjacent":[280],"normal":[281,341,400],"mucosa":[282],"or":[283],"control":[284],"non-AOM/DSS-treated":[285],"colons.":[286],"Moreover,":[287],"observed":[289],"negative":[291],"correlation":[292],"between":[293],"CD8+":[296],"into":[300,345],"single":[304],"agent":[305],"reduced":[307],"both":[308],"number":[311],"total":[313],"burden.":[316],"Of":[317],"note,":[318],"reversed":[321],"length":[323],"shortening":[324],"was":[326],"characteristic":[327],"tumor-bearing":[329],"mice,":[330],"indicative":[331],"restoration":[334,398],"crypt":[337],"regeneration":[338],"hence":[340],"biology.":[343],"Investigations":[344],"immunological":[347,378],"mechanism(s)":[348],"responsible":[349],"currently":[355],"underway.":[356],"Taken":[357],"together,":[358],"our":[359],"data":[360],"suggest":[361],"delivering":[365],"oxygen":[366,434],"regions,":[371],"be":[373],"sufficient":[374],"induce":[376],"change":[379],"immunopermissive":[390],"state,":[391],"leading":[392],"responses":[395],"physiology.":[401],"Citation":[402],"Format:":[403],"Kevin":[404],"G.":[405],"Leong,":[406],"Yuqiong":[407],"Pan,":[408],"Changan":[409],"Guo,":[410],"Padmini":[411],"Narayanan,":[412],"Jonathan":[413],"A.":[414],"Winger,":[415],"Stephen":[416],"P.":[417],"Cary,":[418],"Natacha":[419],"Le":[420],"Moan,":[421],"Ana":[422],"Krtolica.":[423],"Reversal":[424],"novel":[433],"carrier":[435],"immunosensitizes":[437],"[abstract].":[442],"In:":[443],"Proceedings":[444],"American":[447],"Association":[448],"Cancer":[450,463],"Research":[451],"Annual":[452],"Meeting":[453],"2018;":[454],"2018":[455],"Apr":[456],"14-18;":[457],"Chicago,":[458],"IL.":[459],"Philadelphia":[460],"(PA):":[461],"AACR;":[462],"Res":[464],"2018;78(13":[465],"Suppl):Abstract":[466],"nr":[467],"1744.":[468]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2018-08-22T00:00:00"}